RESUMEN
The transient receptor potential vanilloid 1 (TRPV1) can modulate stress-related behaviours, thus representing an interesting target for new antidepressant drugs. TRPV1 can trigger glutamate release and nitric oxide synthesis in the brain, mechanisms also involved in the neurobiology of depression. However, it is not known if these mechanisms are involved in TRPV1-induced behavioural effects. Therefore, the aim of this study was to verify if the antidepressant-like effect induced by a TRPV1 antagonist in mice submitted to the forced swimming test (FST) would be facilitated by combined treatment with neuronal nitric oxide synthase (nNOS) inhibition and N-methyl-D-aspartate (NMDA) blockade. Male Swiss mice were given (intracerebroventricular) injections of capsazepine (CPZ) (TRPV1 antagonist - 0.05/0.1/0.3/0.6 nmol/µl), and AP7 (NMDA antagonist - 1/3/10 nmol/µl) or N-propyl-L-arginine (NPA, nNOS inhibitor - 0.001/0.01/0.1 nmol/µl), and 10 min later, submitted to an open field test, and immediately afterwards, to the FST. An additional group received coadministration of CPZ and AP7 or CPZ and NPA, in subeffective doses. The results demonstrated that CPZ (0.1 nmol/µl), AP7 (3 nmol/µl) and NPA (0.01/0.1 nmol/µl) induced antidepressant-like effects. Moreover, coadministration of subeffective doses of CPZ and AP7 or CPZ and NPA induced significant antidepressant-like effects. Altogether, the data indicate that blockade of TRPV1 receptors by CPZ induces antidepressant-like effects and that both nNOS inhibition and NMDA blockade facilitate CPZ effects in the FST.
Asunto(s)
Antidepresivos/uso terapéutico , Capsaicina/análogos & derivados , Depresión/tratamiento farmacológico , Ácido Glutámico/metabolismo , Óxido Nítrico/metabolismo , Natación/psicología , 2-Amino-5-fosfonovalerato/análogos & derivados , 2-Amino-5-fosfonovalerato/farmacología , Animales , Apomorfina/análogos & derivados , Apomorfina/farmacología , Arginina/farmacología , Capsaicina/uso terapéutico , GMP Cíclico/metabolismo , Depresión/metabolismo , Depresión/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Inhibidores Enzimáticos/farmacología , Conducta Exploratoria/efectos de los fármacos , Masculino , Microinyecciones , Nitroprusiato/metabolismo , Ratas , Receptores de N-Metil-D-Aspartato/metabolismo , Estadísticas no ParamétricasRESUMEN
Complexes of yttrium(III) and dysprosium(III) with the traditional Chinese medicine active ingredient oxoglaucine (OG), namely [Y(OG)2(NO3)3]·CH3OH (1) and [Dy(OG)2(NO3)3]·H2O (2), were synthesized and characterized by elemental analysis, IR, ESI-MS, (1)H and (13)C NMR as well as single-crystal X-ray diffraction analysis. In vitro the complexes exhibited higher anticancer activity than the free ligand OG against the tested cancer cell lines. Among the tested cell lines, HepG2 is the most sensitive to the complexes. Complex 2 can trigger DNA damage in HepG2 cells, resulting in cell cycle arrest in the S phase and leading to cell apoptosis. The S phase cell-cycle arrest is caused via the ATM (ataxia-telangiectasia mutated)-Chk2-Cdc25A pathway. Chk2 is phosphorylated and activated in an ATM-dependent manner. It, in turn, phosphorylates Cdc25A phosphatise on serine124, causing the inactivation of Cdc25A in ubiquitin-mediated proteolytic degradation. The cyclin-Cdk complexes of the S phase could also be inhibited by limited supply of cyclins A and E. This irreversible cell cycle arrest process ultimately induces mitochondria-involved apoptotic cell death via the activation of Bcl-2 protein. Complex e2 ffectively inhibited tumour growth in the BEL-7402 xenograft mouse model and exhibited higher safety in vivo than cisplatin.
Asunto(s)
Antineoplásicos , Apomorfina/análogos & derivados , Complejos de Coordinación , Disprosio , Inhibidores de Topoisomerasa , Itrio , Animales , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Apomorfina/química , Apomorfina/farmacología , Apomorfina/uso terapéutico , Apoptosis/efectos de los fármacos , Puntos de Control del Ciclo Celular/efectos de los fármacos , Línea Celular , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Complejos de Coordinación/química , Complejos de Coordinación/farmacología , Complejos de Coordinación/uso terapéutico , ADN/metabolismo , Daño del ADN , Disprosio/química , Disprosio/farmacología , Disprosio/uso terapéutico , Humanos , Medicina Tradicional China , Ratones , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Fase S/efectos de los fármacos , Solubilidad , Inhibidores de Topoisomerasa/química , Inhibidores de Topoisomerasa/farmacología , Inhibidores de Topoisomerasa/uso terapéutico , Carga Tumoral/efectos de los fármacos , Agua/química , Difracción de Rayos X , Itrio/química , Itrio/farmacología , Itrio/uso terapéuticoRESUMEN
OBJECTIVE: To investigate the chemical constituents of Corydalis yanhusuo. METHOD: The compounds were isolated and purified by column chromatography over macroporous absorption resin, silica gel, and Sephadex LH-20. Their structures were elucidated on the basis of physicochemical properties and spectral data. RESULT: 22 compounds were isolated and identified as corydaline (1), tetrahydropalmatine (2), protopine (3), tetrahydrocorysamine (4), tetrahydrocoptisine (5) , tetrahydroberberine (6), tetrahydrocolumbamine (7), noroxyhydrastine (8), dehydrocorydaline (9), glaucine (10), columbamine (11), 8-oxocoptisine (12), 13-methyl-columbamine (13), coptisine (14), palmatine (15), herberine (16), oxoglaucine (17), 13-methyl-palmatrubine (18), dehydrocorybulbine (19), stepharanine (20), adenosine (21), and N5 -acetylornithine (22). CONCLUSION: Compounds 13, 20, 21, and 22 were isolated from this plant for the first time.
Asunto(s)
Corydalis/química , Extractos Vegetales/análisis , Extractos Vegetales/aislamiento & purificación , Adenosina/análisis , Adenosina/aislamiento & purificación , Alcaloides/análisis , Alcaloides/aislamiento & purificación , Apomorfina/análogos & derivados , Apomorfina/análisis , Apomorfina/aislamiento & purificación , Aporfinas/análisis , Aporfinas/aislamiento & purificación , Berberina/análisis , Berberina/aislamiento & purificación , Alcaloides de Berberina/análisis , Alcaloides de Berberina/aislamiento & purificación , Cromatografía Liquida/métodos , Espectrometría de Masa por Ionización de Electrospray/métodosRESUMEN
The alkaloid oxoglaucine (OG), which is a bioactive component from traditional Chinese medicine (TCM), was synthesized by a two-step reaction and used as the ligand to react with transition metal salts to give four complexes: [OGH][AuCl(4)]·DMSO (1), [Zn(OG)(2)(H(2)O)(2)](NO(3))(2) (2), [Co(OG)(2)(H(2)O)(2)](ClO(4))(2) (3), and [Mn(OG)(2)(H(2)O)(2)](ClO(4))(2) (4). The crystal structures of the metal complexes were confirmed by single crystal X-ray diffraction. Complex 1 is an ionic compound consisting of a charged ligand [OGH](+) and a gold complex [AuCl(4)](-). Complexes 2-4 all have similar structures (inner-spheres), that is, octahedral geometry with two OG coordinating to one metal center and two aqua ligands occupying the two apical positions of the octahedron, and two NO(3)(-) or ClO(4)(-) as counteranions in the outer-sphere. The complexation of OG to metal ion was confirmed by ESI-MS, capillary electrophoresis and fluorescence polarization. The in vitro cytotoxicity of these complexes toward a various tumor cell lines was assayed by the MTT method. The results showed that most of these metal-oxoglaucine complexes exhibited enhanced cytotoxicity compared with oxoglaucine and the corresponding metal salts, with IC(50) values ranging from 1.4 to 32.7 µM for sensitive cancer cells, which clearly implied a positive synergistic effect. Moreover, these complexes appeared to be selectively active against certain cell lines. The interactions of oxoglaucine and its metal complexes with DNA and topoisomerase I were investigated by UV-vis, fluorescence, CD spectroscopy, viscosity, and agarose gel electrophoresis, and the results indicated that these OG-metal complexes interact with DNA mainly via intercalation. Complexes 2-4 are metallointercalators, but complex 1 is not. These metal complexes could effectively inhibit topoisomerase I even at low concentration. Cell cycle analysis revealed that 1-3 caused S-phase cell arrest.
Asunto(s)
Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Apomorfina/análogos & derivados , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Animales , Apomorfina/química , Apomorfina/farmacología , Bovinos , Ciclo Celular/efectos de los fármacos , Línea Celular , Complejos de Coordinación/química , Complejos de Coordinación/farmacología , Cristalografía por Rayos X , ADN/metabolismo , ADN-Topoisomerasas de Tipo I/metabolismo , Humanos , Modelos Moleculares , Neoplasias/tratamiento farmacológico , Inhibidores de Topoisomerasa I/química , Inhibidores de Topoisomerasa I/farmacología , Elementos de Transición/química , Elementos de Transición/farmacologíaRESUMEN
Two isochinoline alkaloids, glaucine and oxoglaucine were investigated for their suggested anti-inflammatory influence concerning nitric oxide and cytokine production. Mouse peritoneal macrophages were stimulated with different Toll-like receptor (TLR) ligands such as LPS for TLR4, zymosan for TLR2 and CpG for TLR9. The alkaloids inhibited TNF-alpha and IL-6 production induced by these ligands. In regard to IL-12 suppressive effect was registered in the case of CpG stimulation. Glaucine succeeded to enhance LPS and zymosan-induced IL-10 production. The reduction of pro-inflammatory cytokines and increase of anti-inflammatory IL-10 are indicative for their use in different acute and chronic inflammatory diseases.
Asunto(s)
Alcaloides/farmacología , Antiinflamatorios/farmacología , Apomorfina/análogos & derivados , Aporfinas/farmacología , Macrófagos/efectos de los fármacos , Papaveraceae/química , Extractos Vegetales/farmacología , Receptores Toll-Like/metabolismo , Animales , Apomorfina/farmacología , Citocinas/metabolismo , Inmunidad/efectos de los fármacos , Lipopolisacáridos , Macrófagos/metabolismo , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/biosíntesis , Componentes Aéreos de las Plantas , Relación Estructura-Actividad , ZimosanRESUMEN
Bioactivity-directed fractionation led to the isolation of 19 compounds, including three oxoaporphines, oxopurpureine (5), oxonuciferine (6), and oxoglaucine (7); three aporphines, (+)-predicentrine (8), (-)-glaucine (9), and thalbaicalidine (10); one aporphine sensu stricto, N-formyl-purpureine (11); one proaporphine, glaziovine; one phenanthrene, thalicpureine (12); two 6a,7-dehydroaporphines, dehydrolirinidine (13) and 7-hydroxy-dehydroglaucine (14); four flavonoids, quercetin-3-O-rhamnoside, kaempferol-3-O-rhamnoside, isorhamnetin-3-O-rhamnoside, and tanarixetin-3-O-rhamnoside; one purine, adenine; one lactam amide, squamolone; and two steroids, beta-sitosterol and beta-sitosterol-beta-D-glucoside from the MeOH extract of the leaves of Formosan Annona purpurea. Among them, 11-14 were characterized as new compounds and alkaloids, 5-8, 10, and 12-14 exhibited significant antiplatelet aggregation activity.
Asunto(s)
Alcaloides/aislamiento & purificación , Apomorfina/análogos & derivados , Aporfinas/aislamiento & purificación , Plantas Medicinales/química , Inhibidores de Agregación Plaquetaria/aislamiento & purificación , Alcaloides/farmacología , Animales , Apomorfina/aislamiento & purificación , Apomorfina/farmacología , Aporfinas/farmacología , Cromatografía Líquida de Alta Presión , Técnicas In Vitro , Inhibidores de Agregación Plaquetaria/farmacología , Conejos , Espectrofotometría Infrarroja , Espectrofotometría UltravioletaRESUMEN
In the present study we tested the effect of four aporphine alkaloids, corytuberine, magnoflorine, isothebaine and isocorydine, on the isolated rat aorta. Corytuberine and magnoflorine showed little effect as relaxants in KCl- and noradrenaline-induced contractions. They did not inhibit the phenylephrine concentration-response curve (CRC). Isothebaine and isocorydine showed relaxant properties in the rat aorta. They relaxed the contractions induced by noradrenaline to a greater extent than those induced by KCl and they also inhibited the noradrenaline-induced contraction in calcium-free solution. These alkaloids competitively shifted the phenylephrine CRC to the right and non-competitively the serotonin CRC. They seemed to inhibit both the influx of calcium into the cell, preferentially through receptor-regulated calcium channels, and the release of calcium from intracellular stores. Moreover, they appear to be antagonists of alpha 1-adrenoceptors. Study of structure-activity relationships of aporphine alkaloids in the inhibition of calcium influx via potential-operated Ca2+ channels yielded information indicative of the interaction of these substances with the benzothiazepine receptor.
Asunto(s)
Apomorfina/análogos & derivados , Aporfinas/farmacología , Bloqueadores de los Canales de Calcio/farmacología , Relajación Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Parasimpatolíticos/farmacología , Plantas Medicinales , Animales , Aorta , Apomorfina/farmacología , Aporfinas/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Técnicas In Vitro , Masculino , Norepinefrina , Parasimpatolíticos/aislamiento & purificación , Fenilefrina , Cloruro de Potasio , Ratas , Ratas Wistar , Serotonina , Relación Estructura-Actividad , Tebaína/análogos & derivados , Tebaína/químicaAsunto(s)
Apomorfina/análogos & derivados , Corticosterona/sangre , Epinefrina/metabolismo , Hipotálamo/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Apomorfina/farmacología , Ácido Homovanílico/metabolismo , Hipotálamo/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas , Espiperona/farmacologíaRESUMEN
Slices of the rabbit caudate nucleus were preincubated with 3H-dopamine or 3H-choline and then superfused and stimulated electrically. DiPr-5,6-ADTN reduced the stimulation-evoked overflow of tritium over the same concentration range, independently of whether slices had been preincubated with 3H-dopamine or 3H-choline, and the same was true for apomorphine, NPA and pergolide. Three other putative dopamine receptor agonists, namely 3-PPP, DPI and SKF 38393, failed to decrease the evoked overflow of tritium. Each of six antagonists--(-)-sulpiride, (+)-sulpiride, CGP 11109 A, cis-flupentixol, domperidone and corynanthine--increased the evoked overflow over the same concentration range in experiments with 3H-dopamine and in those with 3H-choline. For each of these antagonists except cis-flupentixol, and also for chlorpromazine, haloperidol and rauwolscine, the pA2 values against apomorphine obtained in 3H-dopamine and in 3H-choline experiments were closely similar. The antagonist effect of cis-flupentixol against apomorphine was not purely competitive. (-)-Sulpiride was a more potent antagonist than (+)-sulpiride, and cis-flupentixol was more potent than trans-flupentixol. This study supplements a previous one in which (+/-)-sulpiride, metoclopramide and molindone were used as antagonists. It is a functional in vitro approach to receptor characterization, as opposed to radioligand binding studies or in vivo investigations. The results show that a large number of dopamine receptor agonists and antagonists are unable to distinguish between the presynaptic, release-inhibiting dopamine autoreceptors and those postsynaptic dopamine receptors which, when activated, depress the release of acetylcholine.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Núcleo Caudado/metabolismo , Receptores Dopaminérgicos/metabolismo , 2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina , Acetilcolina/metabolismo , Animales , Apomorfina/análogos & derivados , Apomorfina/farmacología , Benzazepinas/farmacología , Colina/metabolismo , Clonidina/farmacología , Femenino , Masculino , Piperidinas/metabolismo , ConejosRESUMEN
A solid basis for the M4-approach has been developed over the past 10 years. Recent examples of the production of difficult-to-synthesize mammalian metabolites through microbial transformations attest to the utility of the methodology. There is, however, much more to be done. Model studies should be conducted to test parallels between microbial and mammalian S- and N-oxidations, O-glucuronidations, and ester and amide hydrolyses. Subsequently, even greater applications of M4- work can be envisioned. We have been pleased to see our colleagues in industry and academia adopt the M4- approach to solve difficult pharmacological and toxicological problems. In large measure, this has been our greatest reward for efforts initially presented before the membership of the American Society of Pharmacognosy in 1973.
Asunto(s)
Mamíferos/metabolismo , Preparaciones Farmacéuticas/metabolismo , Acronina/metabolismo , Animales , Apomorfina/análogos & derivados , Apomorfina/metabolismo , Biotransformación , Remoción de Radical Alquila , Elipticinas/metabolismo , Ergolinas/análogos & derivados , Ergolinas/metabolismo , Cobayas , Humanos , Hidroxilación , Imipramina/metabolismo , Modelos Biológicos , Papaverina/metabolismoRESUMEN
Parkinsonism is a movement disorder related to a central nervous system dopamine deficiency. L-dopa with or without carbidopa is presently the most effective medication. The use of this drug should be delayed as long as possible, and overtreatment should be avoided. Complications of long-term parkinsonism may respond in part to the direct dopamine receptor agonists. Physical therapy and emotional support for the patients and their families are an integral part of the management of the patient with Parkinson's disease.